Response to "Comment on 'The characteristics and risk factors of cerebrovascular events in young systemic lupus erythematosus patients: A case-control study" [0.03%]
年轻系统性红斑狼疮患者脑血管事件的特点及危险因素的病例对照研究——对“评论”的回复
Uei-Hsiang Hsu,Yu-Tsan Lin,Bor-Luen Chiang
Uei-Hsiang Hsu
Response to "Platelet rich plasma in adhesive capsulitis from symptomatic relief to tissue restoration and inflammatory control" [0.03%]
对“富血小板血浆在肩周炎的应用从症状缓解到组织修复及炎症控制”的答复
Shu-Mei Yang,Ming-Yen Hsiao
Shu-Mei Yang
Rethinking thyroid dysfunction after proton and photon radiotherapy for head and neck cancer [0.03%]
重思头颈肿瘤质子和光子放射治疗后的甲状腺功能异常问题
Jia Liao,Huazhen Wu,Lishan Hu et al.
Jia Liao et al.
SGLT2 inhibitors and geriatric syndromes in older adults with type 2 diabetes: A real-world cohort study [0.03%]
钠-葡萄糖协同转运蛋白2抑制剂与老年2型糖尿病患者的综合征:一项真实世界队列研究
Chun-Ying Lee,Tzu-Jung Fang,Chun-Hao Jen et al.
Chun-Ying Lee et al.
Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors provide cardiorenal benefits in type 2 diabetes mellitus (T2DM), but concerns persist regarding potential exacerbation of geriatric syndromes through osmotic d...
Response to comment on "Considering the unmeasured impact of 5-fluorouracil dose intensity in the interpretation of optimal initial relative dose intensity of modified FOLFIRINOX" [0.03%]
关于“在改良型FOLFIRINOX最佳初始相对剂量强度解释中考虑氟尿嘧啶未测量影响的回应”的评论回复
I-Wei Ho,Chung-Pin Li,Shih-Hung Yang et al.
I-Wei Ho et al.
Comment on "Worldwide physicians' attitudes toward euthanasia and physician-assisted death: A systematic literature review" [0.03%]
关于“全球医师对安乐死和医生协助死亡的态度:系统文献综述”的评论
Fnu Bhuvan,Abhishek Prasad,Hasnain Ali et al.
Fnu Bhuvan et al.
Toward a coordinated pediatric system for developmental dysplasia of the hip: A response [0.03%]
关于儿童髋关节发育不良协作体系的建立与思考
Chien-Chung Kuo,Yin-Ting Chen
Chien-Chung Kuo